uniQure To Present At Upcoming Investor Conferences In September

Lexington, MA and Amsterdam, the Netherlands, August 17, 2016 - uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that members of its leadership team will present an overview of the company's programs and progress at several upcoming investor conferences. These meetings include the following:

• CITI 11th Annual Biotech Conference
Venue: The Mandarin Oriental Hotel, Boston MA
Presenter: Harald Petry, Ph.D., Chief Scientific Officer
Title, Date and Time: "Gene Therapy, A New Era" panel discussion, Wednesday, September 7, 1:00 p.m. EDT

• Rodman & Renshaw 18th Annual Global Investment Conference
Venue: The Lotte New York Palace Hotel, New York City
Presenter: Matthew Kapusta, Chief Financial Officer
Date and Time: Monday, September 12, 3:50 p.m. EDT
Webcast: http://wsw.com/webcast/rrshq26/qure

• Leerink Partners Rountable Series: Rare Disease & Immuno- Oncology
Venue: The Lotte New York Palace Hotel, New York City
Presenter: Christian Meyer, M.D., Chief Medical Officer
Date and Time: Wednesday, September 28, 2:35 p.m. EDT
Webcast: http://wsw.com/webcast/leerink27/qure

The webcasts for the Rodman & Renshaw 18th Annual Global Investment Conference and the Leerink Partners Roundtable Series, also can be accessed by the link displayed in the "Events" section on the "Media" page of the uniQure website at: http://www.uniqure.com/news/calendar-of-events/. The replay of the webcast will be available one hour after the conclusion of the live events and archived on the uniQure website for at least 30 days following the webcast.

About uniQure

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com

Back to news